Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | GAA | P10253 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | GFER | P55789 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 6/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6558040 | 0.88 | ALDH1A1 (0.63) | ALDH1A1MAPTGAAMEN1KMT2A | |
| SCHEMBL6815441 | 0.86 | ALDH1A1 (0.69) | ALDH1A1MAPTGAAMEN1KMT2A | |
| SCHEMBL8063648 | 0.85 | ALDH1A1 (0.82) | ALDH1A1MAPTGAAMEN1KMT2A | |
| SCHEMBL4351772 | 0.84 | EPHX2 (0.63) | ALDH1A1MAPTGAAMEN1KMT2A | |
| SCHEMBL9126998 | 0.83 | ALDH1A1 (0.69) | ALDH1A1MAPTGAAMEN1KMT2A | |
| SCHEMBL13945695 | 0.82 | EPHX2 (0.59) | MAPTKMT2ATP53SMN1; SMN2RAB9A | |
| Phenyl 4-Methoxyphenylcarbamate SCHEMBL11183948 | 0.82 | ALDH1A1 (0.90) | ALDH1A1MAPTGAAMEN1KMT2A | |
| SCHEMBL21295428 | 0.82 | SMN1; SMN2 (0.74) | ALDH1A1MAPTGAAMEN1KMT2A | |
| SCHEMBL2092785 | 0.82 | SMN1; SMN2 (0.59) | ALDH1A1MAPTGAALMNATP53 | |
| SCHEMBL23240070 | 0.81 | ALDH1A1 (0.67) | ALDH1A1MAPTGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070212302-A1 | Preparation and Use of a Stable Formulation of Allosteric Effector Compounds | ALLOS THERAPEUTICS, INC. (US) | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070212302-A1 | Preparation and Use of a Stable Formulation of Allosteric Effector Compounds | PRKAA2, PDE7A, CHRM3 | ALDH1A1 3307/4885MAPT 2105/4885GAA 3769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.